Interestingly, ATXN2 also serves as a major modifier of ALS, with significant interactions observed between ATXN2 and pathologically expanded HRE-induced C9orf72 deletions, leading to ALS-frontotemporal dementia (ALS-FTD) pathogenesis. The gene discussed is ATXN2; the disease is frontotemporal dementia.